Status:
WITHDRAWN
Preventing COVID-19 in Healthcare Workers With HCQ: A RCT
Lead Sponsor:
Stony Brook University
Conditions:
Covid-19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Healthcare workers (HCW) at risk of Covid-19 will have baseline serology for SARS-CoV-2 to see if they are already immune to Covid-19. HCW will get baseline assessment and if meeting inclusion criteri...
Detailed Description
Healthcare workers (HCW) at risk of Covid-19 will have baseline serology for SARS-CoV-2 to see if they are already immune to Covid-19. HCW will get baseline assessment and if meeting inclusion criteri...
Eligibility Criteria
Inclusion
- Healthcare worker at risk of Covid-19
Exclusion
- Known hypersensitivity or allergic reactions to 4-aminoquinoline compounds or its ingredients.
- Current, or history of, ocular macular disease or retinal damage.
- Current, or history of, subnormal glomerular filtration.
- Current use of tamoxifen citrate.
- Current, or history of, cardiomyopathy, atrial, nodal, or ventricular arrhythmias, torsades de pointes, conduction disorders (bundle branch block/atrio-ventricular heart block) or biventricular hypertrophy.
- Subjects taking other drugs that have the potential to prolong QT interval if taken with HCQ.
Key Trial Info
Start Date :
April 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04347889
Start Date
April 20 2020
End Date
December 30 2020
Last Update
November 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.